- Kelley School of Business Academy of Alumni Fellows (2002)
Ron Dollens serves on the Kelley School Dean's Advisory Council and the IU School of Medicine Dean's Advisory Group. In addition, Mr. Dollens is a member of IU's Advanced Research and Technology Institute Board of Directors.
Mr. Dollens is president and chief executive officer of Guidant Corporation, a $2.5 billion company traded on the New York and Pacific Stock Exchanges (NYSE and PCX: GDT).
Prior to the formation of Guidant, Mr. Dollens served as president of Eli Lilly and Company's Medical Devices and Diagnostics Division (MDD). In 1985, Mr. Dollens was named senior vice president of sales, marketing, and product development for Advanced Cardiovascular Systems (ACS), an MDD company headquartered in Santa Clara, California. In 1988, he became president and chief executive officer of ACS. He assumed his current post as president and chief executive officer of Guidant when the company was formed in 1994.
Mr. Dollens received a bachelor of science degree in pharmacy from Purdue University, and a master of business administration degree in marketing from the Kelley School.
Mr. Dollens is a member of the board of directors of Advanced Medical Technology Association (AdvaMed, formerly HIMA), Alliance for Aging Research, Healthcare Leadership Council, Indiana Health Industry Forum, Kinetic Concepts Inc., and Beckman Coulter Corporation. Active in civic affairs, he also serves on the boards of Butler University, Eiteljorg Museum, St. Vincent Hospital Foundation, and the Indiana State Symphony Society.